• Nie Znaleziono Wyników

Mitral valve prosthesis abruption

N/A
N/A
Protected

Academic year: 2022

Share "Mitral valve prosthesis abruption"

Copied!
2
0
0

Pełen tekst

(1)

IMAGES IN CARDIOLOGY

Cardiology Journal 2007, Vol. 14, No. 3, pp. 314–315 Copyright © 2007 Via Medica ISSN 1897–5593

314 www.cardiologyjournal.org

Address for correspondence: Dr med. Barbara Brzezińska Cardiology Department of T. Marciniak Hospital

Traugutta 116, 53–313 Wrocław, Poland e-mail: barbarabrzezinska@hotmail.com

Mitral valve prosthesis abruption

Barbara Brzezińska

Cardiology Department of T. Marciniak Hospital, Wrocław, Poland

A 63-year-old woman underwent an operation for replacement of the mitral valve owing to its hemodynamically significant regurgitation. The mechanical prosthesis (SJM 27) was implanted three years ago. Furthermore, this patient had a history of continuous atrial fibrillation and perma- nent cardiac pacing (VVI) due to bradyarrhythmia, ischemic brain stroke, pulmonary embolism and hyperthyroidism. The patient had been being un- der regular echocardiographic control and hitherto mitral valve prosthesis function had been evaluat- ed as normal.

The patient was admitted due to increasing (within the past three days) dyspnoea, palpitation and chest pain. Massive pulmonary venostasis and tachyarrhythmia (160/min) were demonstrated in a physical examination. Laboratory examinations revealed an increased level of cardiac troponin (Tn I 3.02 ng/mL) and negative coronarography.

Spiral CT angiography of pulmonary arteries was normal.

The transthoracic echocardiogram demonstrated an abnormal position of the mitral valve prosthesis.

It was relocated towards the left atrium. In the apical views, the prosthesis echogram was regis- tered about 10–15 mm above the level of the native mitral annulus (Figs. 1, 2). Mobility of the mitral prosthesis was abnormally large in the vertical di- rection. Around the posterior pole of the prosthesis annulus, a lack of contact between the prosthesis and cardiac wall was observed (Fig. 3). In this place, a perivalvular shunt could be detectable (Fig. 4).

In colour Doppler mapping, a left atrio-ventricular flow seemed, in some places, a bit “deluging” (Fig. 4).

This feature also suggested a perivalvular shunt.

The pressure gradient of the mitral prosthesis was slightly increased (22 mm Hg). Evident features of infective endocarditis were not noted in the tran- sthoracic echocardiogram.

Figure 1. Apical 4-chamber view (A4C) showing the prosthesis echogram (arrows) 15 mm above the level of native mitral annulus (arrows).

Figure 2. Apical 3-chamber view (A3C) showing the pro- sthesis echogram 10–15 mm (arrow) above the level of the native mitral annulus (arrow).

(2)

315 Barbara Brzezińska, Mitral valve prosthesis abruption

www.cardiologyjournal.org

Figure 4. Colour-Doppler in A3C showing the perivalvu- lar shunt (behind the posterior pole of the prosthesis) and “deluging” tranmitral flow (arrows).

Figure 3. Apical 3-chamber view showing lack of con- tact between the prosthesis and cardiac wall (arrow).

Because of the suspicion of prosthesis abrup- tion, the patient was qualified for an urgent reoper- ation. An uncomplicated replacement of the mitral valve prosthesis was performed. The mitral valve

prosthesis abruption along a large segment of its circumference was affirmed. Evidence of prosthesis infection was not present.

Cytaty

Powiązane dokumenty

A 60 year-old woman with rheumatic mitral stenosis underwent re-replacement of Cross- -Jones caged lens mitral valve prosthesis, 36 years after valve implantation.. In 1968,

Historically she had a primum atrial septal defect, a cleft mitral valve, and atrial septal defect closure with mitral valuloplasty.. She had linear splinter hemorrhages under

figure 1 A – an immobilized mitral prosthesis disc (arrow); 3‑dimensional transesophageal echocardiography (3D TEE), left atrial view; B – pathological masses on the

trast, MV repair in secondary MR is associated with increased recurrence of regurgitation, while the results in rheumatic disease are in between these 2 etiologies, although

Appropriate estimation of the etiology of mitral regurgitation (MR) is a crucial part of adequate disease management. No previous studies have compared postoperative

As a result it was noted that TAVI with a CoreValve (Medtronic, Inc, Minneapolis, MN, USA) was technically possible in high-risk patients with mechanical mitral valves or

An 81-year-old man, who had undergone a complex cardiosurgical procedure 8 years previously (aortic valve replacement by Medtronic Hancock II 23 mm and mitral valve replacement

W badaniach oceniaj¹cych bezpieczeñstwo i skutecz- noœæ korekcji niedomykalnoœci mitralnej technik¹ „brzeg do brzegu” wykonywanej drog¹ przezskórn¹ sprawdzane s¹